PRESS RELEASE published on 02/16/2026 at 07:30, 7 months ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
BRIEF published on 02/12/2026 at 07:35, 7 months 4 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
BRIEF published on 02/10/2026 at 07:35, 7 months 6 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
PRESS RELEASE published on 02/10/2026 at 07:30, 7 months 6 days ago Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026 Nicox to present NCX 470 Phase 3 data at AGS Annual Meeting 2026 with podium presentations showcasing clinical study results and efficacy of the ophthalmic solution Clinical Study Ophthalmology Nicox NCX 470 AGS Annual Meeting 2026
BRIEF published on 01/20/2026 at 07:35, 7 months 27 days ago Nicox announces its participation in several congresses in 2026 Glaucoma Ophthalmology Nicox NCX 470 Congress 2026
BRIEF published on 01/20/2026 at 07:35, 7 months 27 days ago Nicox Announces 2026 Conference Participation and Data Presentations Scientific Data Ophthalmology NCX 470 Conference Participation 2026 Events
PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 27 days ago Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific Data Presentations Nicox to attend key ophthalmology conferences and present scientific data at AGS 2026 Annual Meeting. Management team available for meetings. Developing innovative eye health solutions Conference Scientific Data Ophthalmology Nicox Eye Health
BRIEF published on 12/16/2025 at 07:35, 9 months ago Nicox Finalizes Key Data for NCX 470 NDA Submission by H1 2026 Clinical Trials Ophthalmology Nicox NCX 470 NDA Submission
PRESS RELEASE published on 12/16/2025 at 07:30, 9 months ago Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026 Nicox completes key data generation for NCX 470 new drug application submission in H1 2026, including clinical trial and stability data. U.S. and China submissions on track FDA Clinical Trials Nicox NCX 470 New Drug Application
BRIEF published on 10/23/2025 at 07:35, 10 months 24 days ago Nicox Releases First Half 2025 Financial Results Financial Results Debt Repayment Ophthalmology Cost Control NCX 470
Published on 09/16/2026 at 14:00, 10 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 40 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 47 minutes ago SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 13:15, 55 minutes ago Impauer Technologies Announces Launch Of New Corporate Website And Provides OTC Symbol Update
Published on 09/16/2026 at 13:00, 1 hour 10 minutes ago Alaska Energy Metals Acquires 100% Of The Canwell Ni-Cu-Co-Pge Claim Block, Nikolai Nickel Project, Alaska
Published on 09/16/2026 at 14:05, 5 minutes ago Bank of Canada Selects the CanDeal Data & Analytics ("DNA") Reference Pricing Service as its pricing source for Canadian fixed income securities
Published on 09/16/2026 at 14:00, 10 minutes ago Alain de Botton joins Hakluyt's International Advisory Board
Published on 09/16/2026 at 14:00, 10 minutes ago 100 years after the Great Miami Hurricane: Florida hurricane could cause USD 300 billion or more in insured losses, finds Swiss Re Institute
Published on 09/16/2026 at 13:25, 45 minutes ago 2026 Amos International Candy Festival Celebrates Sweet Innovation for Happiness & Health
Published on 09/16/2026 at 13:00, 1 hour 10 minutes ago TDCX Opens Lisbon Campus as Its Next European Growth Engine
Published on 09/16/2026 at 07:00, 7 hours 10 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 20 hours 10 minutes ago Report on the Combined General Meeting of the 10th of September 2026
Published on 09/15/2026 at 17:45, 20 hours 25 minutes ago EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP
Published on 09/15/2026 at 17:43, 20 hours 27 minutes ago Aéroports de Paris S.A - August 2026 traffic figures
Published on 09/15/2026 at 17:01, 21 hours 9 minutes ago Number of shares and voting rights - August 2026 (In French only)
